They're reference designs for a reason.

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

Geoff Steward and Rebecca Newman of Addleshaw Goddard explain how they secured victory in a rare ‘genericide’ case and why the work went beyond the courtroom Dryrobe successfully sued competitor ...

Sufficiently idiosyncratic to resist comparison with competitors. Yet there is a paradox at the heart of commercial success. As a brand becomes stronger and more widespread, it may also become more ...

Thousands of low- and middle-income residents in Cook County, Illinois, are set to receive continued financial support following the "historic success" of the Midwestern region's guaranteed income ...

No matter your current running pace and typical distance, in How to Run Faster, certified run coach Matt Meyer and other experts will help you speed up! You will learn crucial speed workouts, ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

A U.S. flag, a U.S. Food and Drug Administration (FDA) logo, a syringe and a vial are seen in this illustration taken May 13, 2025. REUTERS/Dado Ruvic/Illustration (Reuters) -The U.S. Food and Drug ...

Oct 3 (Reuters) - The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in ...